Efficacy and Safety of Ivanesimab in Advanced Lung Cancer

This chapter delves into the findings of the Harmonia study, focusing on the impact of Ivanesimab combined with chemotherapy on non-small cell lung cancer patients with EGFR variants. It highlights the significant improvements in progression-free survival and examines the safety profile of the treatment based on observed adverse events.